2-(n,n-dipropyl)amino-5,6-dihydroxytetralin has been researched along with n-n-propylnorapomorphine in 1 studies
Studies (2-(n,n-dipropyl)amino-5,6-dihydroxytetralin) | Trials (2-(n,n-dipropyl)amino-5,6-dihydroxytetralin) | Recent Studies (post-2010) (2-(n,n-dipropyl)amino-5,6-dihydroxytetralin) | Studies (n-n-propylnorapomorphine) | Trials (n-n-propylnorapomorphine) | Recent Studies (post-2010) (n-n-propylnorapomorphine) |
---|---|---|---|---|---|
37 | 0 | 0 | 274 | 4 | 12 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Costall, B; Lim, SK; Naylor, RJ | 1 |
1 other study(ies) available for 2-(n,n-dipropyl)amino-5,6-dihydroxytetralin and n-n-propylnorapomorphine
Article | Year |
---|---|
Characterisation of the mechanisms by which purported dopamine agonists reduce spontaneous locomotor activity of mice.
Topics: Animals; Antipsychotic Agents; Apomorphine; Bromocriptine; Catecholamines; Dopamine; Dose-Response Relationship, Drug; Imidazolines; Male; Mice; Motor Activity; Prazosin; Receptors, Dopamine; Spiperone; Tetrahydronaphthalenes; Yohimbine | 1981 |